Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
52.50
+5.77 (12.35%)
At close: Nov 13, 2024, 4:00 PM
53.96
+1.46 (2.78%)
After-hours: Nov 13, 2024, 6:15 PM EST
Avidity Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 13, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 6,264 | 671 | 1,474 | 1,115 | 958 | - | |
| Market Cap Growth | 1037.93% | -54.52% | 32.27% | 16.40% | - | - | |
| Enterprise Value | 4,683 | 139 | 1,080 | 703 | 617 | - | |
| Last Close Price | 52.50 | 9.05 | 22.19 | 23.77 | 25.52 | - | |
| PS Ratio | 531.72 | 70.15 | 159.85 | 119.53 | 141.10 | - | |
| PB Ratio | 4.15 | 1.34 | 2.55 | 2.92 | 3.13 | - | |
| P/TBV Ratio | 3.58 | 1.34 | 2.55 | 2.92 | 3.13 | - | |
| EV/Sales Ratio | 462.86 | 14.50 | 117.11 | 75.35 | 90.94 | - | |
| Debt / Equity Ratio | 0.01 | 0.02 | 0.02 | 0.03 | 0.00 | 0.07 | |
| Debt / FCF Ratio | - | - | - | - | - | 2.19 | |
| Asset Turnover | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | 0.05 | |
| Quick Ratio | 17.60 | 7.49 | 11.84 | 13.70 | 22.58 | 9.32 | |
| Current Ratio | 17.76 | 7.58 | 12.00 | 13.86 | 22.74 | 9.35 | |
| Return on Equity (ROE) | -27.76% | -39.34% | -36.27% | -34.32% | -23.62% | -81.19% | |
| Return on Assets (ROA) | -18.33% | -23.24% | -20.97% | -19.38% | -12.85% | -21.47% | |
| Return on Capital (ROIC) | -19.90% | -26.79% | -22.78% | -21.07% | -14.51% | -28.44% | |
| Earnings Yield | -4.48% | -31.65% | -11.80% | -10.59% | -4.63% | - | |
| FCF Yield | -3.01% | -18.38% | -9.43% | -8.84% | -3.99% | - | |
| Buyback Yield / Dilution | -44.08% | -39.97% | -25.91% | -91.24% | -698.49% | -9.53% | |
| Total Shareholder Return | -44.08% | -39.97% | -25.91% | -91.24% | -698.49% | -9.53% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.